Advancing precision medicine: Sengenics i-Ome Discovery microarrays
Drug Discovery World
FEBRUARY 7, 2024
Professor Jonathan Blackburn, Chief Scientific Officer (CSO) of Sengenics, featured in a sponsored DDW Sitting Down With podcast to discuss the advantages of functional protein microarrays, challenges to overcome for biomarker discovery, Sengenics’ new i-Ome Discovery chip, and more. Professor Blackburn began by sharing an overview of his current research, including the work he does with Sengenics.
Let's personalize your content